{"id":"W104393772","doi":"10.1016/j.jchf.2014.09.008","title":"Heart Failure Therapeutics on the Basis of a Biased Ligand of the Angiotensin-2 Type 1 Receptor","year":2015,"lang":"ca","type":"review","venue":"JACC Heart Failure","topic":"Renin-Angiotensin System Studies","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"ca_institutions":"Surgical Specialties (Canada); Canadian VIGOUR Centre; University of Alberta","funders":"National Heart, Lung, and Blood Institute; St. Jude Medical; Amgen; Singulex; Celladon Corporation; BG Medicine; Medtronic; National Institutes of Health; Medicines Company; Novartis; Bristol-Myers Squibb; Astellas Pharma US; European Commission","keywords":"Heart failure; Medicine; Angiotensin II; Clinical endpoint; Internal medicine; Afterload; Cardiology; Natriuretic peptide; Blood pressure; Renin–angiotensin system; Pharmacology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.002967651,0.001465878,0.005844954,0.0003830466,0.0003933371,0.00007355243,0.0009722414,0.001469398,0.0003084511],"category_scores_gemma":[0.001833642,0.0007369681,0.002579627,0.002757147,0.0009964864,0.00008014269,0.0004739968,0.001892465,0.0007630012],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003579079,"about_ca_system_score_gemma":0.002160234,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001525024,"about_ca_topic_score_gemma":0.00008995726,"domain_scores_codex":[0.9908258,0.002255159,0.002427401,0.001103281,0.002344478,0.001043832],"domain_scores_gemma":[0.9890265,0.002205046,0.001677295,0.003804229,0.00295887,0.0003280172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000237986,0.0003139452,0.003656405,0.003181806,0.003245769,0.000007644645,0.001510522,0.00000406584,0.0029623,0.0001099659,0.9786363,0.00613327],"study_design_scores_gemma":[0.000958377,0.001070469,0.001439353,0.03026501,0.003583109,0.0001837664,0.0007337555,0.000008858843,0.003321635,0.00001365503,0.9578096,0.0006124599],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01479675,0.8136318,0.000002522292,0.1596179,0.003298542,0.007523318,0.0005522845,0.000100075,0.0004768233],"genre_scores_gemma":[0.3316128,0.6006038,0.01100914,0.0219209,0.01519795,0.0005573146,0.0005333452,0.002399943,0.01616489],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.316816,"threshold_uncertainty_score":0.9998269,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08285343614601635,"score_gpt":0.3284527010371686,"score_spread":0.2455992648911522,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}